The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Diverse roles of androgen receptor (AR) domains in AR-mediated signaling
Open accessAbstract
Androgens control male sexual development and maintenance of the adult male phenotype. They have very divergent effects on their target organs like the reproductive organs, muscle, bone, brain and skin. This is explained in part by the fact that different cell types respond differently to androgen stimulus, even when all these responses are mediated by the same intracellular androgen receptor. To understand these tissue- and cell-specific readouts of androgens, we have to learn the many different steps in the transcription activation mechanisms of the androgen receptor (NR3C4). Like all nuclear receptors, the steroid receptors have a central DNA-binding domain connected to a ligand-binding domain by a hinge region. In addition, all steroid receptors have a relatively large amino-terminal domain. Despite the overall structural homology with other nuclear receptors, the androgen receptor has several specific characteristics which will be discussed here. This receptor can bind two types of androgen response elements (AREs): one type being similar to the classical GRE/PRE-type elements, the other type being the more divergent and more selective AREs. The hormone-binding domain has low intrinsic transactivation properties, a feature that correlates with the low affinity of this domain for the canonical LxxLL-bearing coactivators. For the androgen receptor, transcriptional activation involves the alternative recruitment of coactivators to different regions in the amino-terminal domain, as well as the hinge region. Finally, a very strong ligand-induced interaction between the amino-terminal domain and the ligand-binding domain of the androgen receptor seems to be involved in many aspects of its function as a transcription factor. This review describes the current knowledge on the structure-function relationships within the domains of the androgen receptor and tries to integrate the involvement of different domains, subdomains and motifs in the functioning of this receptor as a transcription factor with tissue- and cell-specific readouts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA
Luisi, B. F., Xu, W. X., Otwinowski, Z., Freedman, L. P., Yamamoto, K. R., & Sigler, P. B. (1991) · Nature · doi:10.1038/352497a0 · Cited by 1,503 · cited 1×
“On the other hand, in a crystal structure of the AR-DBD on a direct repeat of the 5'-TGTTCT-3', the two DBDs dimerise in a head-to-head conformation similar to what has been observed for GR, PR and ER [Luisi et al., 1991; Roemer et al., 2006; Schwabe et al., 1990; Shaffer et al., 2004].”
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
Structural basis of androgen receptor binding to selective androgen response elements
Shaffer, P. L., Jivan, A., Dollins, D. E., Claessens, F., & Gewirth, D. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401123101 · Cited by 400
Self-citationA surface on the androgen receptor that allosterically regulates coactivator binding
Estébanez-Perpiñá, E., Arnold, L. A., Nguyen, P., Rodrigues, E. D., Mar, E., Bateman, R., Pallai, P., Shokat, K. M., Baxter, J. D., Guy, R. K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708036104 · Cited by 307
Cato, A. C., Henderson, D., & Ponta, H. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04763.x · Cited by 278
Alen, P., Claessens, F., Verhoeven, G., Rombauts, W., & Peeters, B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6085 · Cited by 268
Self-citationNew androgen receptor genomic targets show an interaction with the ETS1 transcription factor
Massie, C. E., Adryan, B., Barbosa‐Morais, N. L., Lynch, A. G., Tran, M. G., Neal, D. E., & Mills, I. G. (2007) · The EMBO Reports · doi:10.1038/sj.embor.7401046 · Cited by 259
Langley, E., Kemppainen, J. A., & Wilson, E. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.92 · Cited by 233
Haelens, A., Tanner, T., Denayer, S., Callewaert, L., & Claessens, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1701 · Cited by 153
Self-citation
Research works printed but not linked: 109
- 10.1210/mend-5-11-1587 · DOI
- 10.1128/MCB.13.10.6326 · DOI
- 10.1074/jbc.M703268200 · DOI · Paper page
- 10.1621/nrs.06001 · DOI · Paper page
- 10.1210/mend.12.8.0153 · doi:10.1210/mend.12.8.0153 · Paper page
- 10.1677/jme.0.0310427 · DOI
- 10.1016/j.tem.2005.09.006 · DOI
- 10.1128/MCB.19.12.8383 · DOI · Paper page
- 10.1128/MCB.01170-07 · DOI
- 10.1101/gad.1564207 · DOI · Paper page
- 10.1158/0008-5472.CAN-07-1646 · DOI
- 10.1093/hmg/ddh181 · DOI · Paper page
- 10.1210/me.2004-0266 · DOI
- 10.1210/me.2003-0313 · DOI
- 10.1074/jbc.M210744200 · DOI
- 10.1016/S0006-291X(03)00902-1 · DOI
- 10.1016/S0090-4295(01)01401-7 · DOI
- 10.1074/jbc.271.43.26772 · DOI
- 10.1093/nar/22.15.3181 · DOI · Paper page
- 10.1128/MCB.19.12.8226 · DOI · Paper page
- 10.1074/jbc.M209322200 · DOI
- 10.1016/S0960-0760(00)00154-0 · DOI · Paper page
- 10.1016/0303-7207(90)90225-W · DOI
- 10.1242/jcs.022103 · DOI · Paper page
- 10.1002/j.1460-2075.1992.tb05141.x · DOI · Paper page
- 10.1210/me.2007-0223 · DOI · Paper page
- 10.1002/pros.20128 · DOI
- 10.1126/science.3283939 · DOI · Paper page
- 10.1016/j.biopha.2006.07.082 · DOI · Paper page
- 10.1016/S0303-7207(02)00104-1 · DOI
- 10.1128/MCB.23.23.8563-8575.2003 · DOI · Paper page
- 10.1074/jbc.M000660200 · DOI · Paper page
- 10.1016/j.drudis.2007.01.003 · DOI · Paper page
- 10.1074/jbc.M602561200 · DOI
- 10.1074/jbc.M203423200 · DOI · Paper page
- 10.1210/me.2005-0351 · DOI · Paper page
- 10.1042/bj20020912 · DOI
- 10.1093/nar/16.12.5263 · DOI · Paper page
- 10.1074/jbc.M008207200 · DOI
- 10.1073/pnas.0408925102 · DOI · Paper page
- 10.1074/jbc.274.52.37219 · DOI · Paper page
- 10.1074/jbc.M403117200 · DOI
- 10.1210/me.2005-0479 · DOI
- 10.1074/jbc.M002807200 · DOI · Paper page
- 10.1016/j.molcel.2004.09.036 · DOI · Paper page
- 10.1074/jbc.M111975200 · DOI · Paper page
- 10.1371/journal.pbio.0020274 · DOI · Paper page
- 10.1074/jbc.272.47.29821 · DOI · Paper page
- 10.1128/MCB.20.16.6040-6050.2000 · DOI · Paper page
- 10.1093/hmg/9.2.267 · DOI · Paper page
- 10.1074/jbc.270.13.7341 · DOI · Paper page
- 10.1074/jbc.M209074200 · DOI · Paper page
- Kasper S., 1994, J Biol Chem, 269, 31763, 10.1016/S0021-9258(18)31761-7 · DOI
- 10.1128/MCB.01297-06 · DOI
- 10.1073/pnas.92.26.12314 · DOI · Paper page
- 10.1038/352077a0 · DOI · Paper page
- 10.1016/j.bcp.2006.05.024 · DOI
- 10.1210/me.2005-0298 · DOI
- 10.1074/jbc.M206374200 · DOI · Paper page
- 10.1128/MCB.25.6.2200-2215.2005 · DOI
- Link K. A., Cancer Res
- 10.1074/jbc.M204751200 · DOI
- 10.1016/j.cell.2008.01.018 · DOI · Paper page
- 10.1128/MCB.19.9.6164 · DOI · Paper page
- 10.1074/jbc.M004571200 · DOI · Paper page
- 10.1073/pnas.94.16.8485 · DOI · Paper page
- 10.1621/nrs.05001 · DOI
- 10.1016/S0092-8674(03)00934-6 · DOI · Paper page
- Metivier R., 2001, Mol Endocrinol, 15, 1953
- 10.1093/emboj/cdg023 · DOI
- 10.1042/BJ20071352 · DOI
- 10.1007/s00439-002-0776-5 · DOI
- 10.1016/S0955-0674(98)80015-X · DOI · Paper page
- 10.1210/mend.13.12.0396 · doi:10.1210/mend.13.12.0396 · Paper page
- 10.1016/j.cell.2008.01.051 · DOI
- 10.1074/jbc.271.39.24151 · DOI · Paper page
- 10.1073/pnas.97.26.14145 · DOI · Paper page
- Rennie P. S., 1993, Mol Endocrinol, 7, 23
- 10.1210/me.2005-0511 · DOI
- 10.1073/pnas.081565498 · DOI · Paper page
- 10.1073/pnas.0610814104 · DOI
- 10.1074/jbc.275.16.12290 · DOI
- 10.1042/bj3410515 · DOI · Paper page
- 10.1038/348458a0 · DOI · Paper page
- 10.1093/emboj/21.9.2242 · DOI
- 10.1515/BC.2005.009 · DOI
- 10.1038/sj.pcan.4500967 · DOI
- 10.1046/j.1432-1033.2002.03276.x · DOI
- 10.1196/annals.1329.068 · DOI
- 10.1002/jcb.10653 · DOI · Paper page
- 10.1210/mend.13.6.0300 · doi:10.1210/mend.13.6.0300 · Paper page
- 10.1074/jbc.M311761200 · DOI
- Tilley W. D., 1996, Clin Cancer Res, 2, 277
- 10.1210/me.2006-0228 · doi:10.1210/me.2006-0228
- 10.1074/jbc.M602567200 · DOI
- 10.1083/jcb.200609178 · DOI · Paper page
- 10.1210/mend.13.9.0347 · DOI
- 10.1074/jbc.275.16.12298 · DOI
- 10.1016/S1096-7192(03)00003-9 · DOI · Paper page
- 10.1042/BST0341089 · DOI
- 10.1016/j.molcel.2007.05.041 · DOI · Paper page
- 10.1210/mend.12.10.0185 · doi:10.1210/mend.12.10.0185 · Paper page
- 10.1210/jc.2006-0372 · DOI
- 10.1074/jbc.M609360200 · DOI · Paper page
- 10.1172/JCI28773. · DOI · Paper page
- Zhou Z. X., 1994, J Biol Chem, 269, 13115, 10.1016/S0021-9258(17)36806-0 · DOI · Paper page
- 10.1016/j.cell.2005.12.032 · DOI · Paper page
- Zilliacus J., 1995, Mol Endocrinol, 9, 389
- 10.1111/j.1365-2265.2007.03069.x · DOI
Cited by
Estrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
Self-citationWatson, P. A., Chen, Y. F., Balbas, M. D., Wongvipat, J., Socci, N. D., Viale, A., Kim, K., & Sawyers, C. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012443107 · Cited by 639
Androgen Signaling in Prostate Cancer
Dai, C., Heemers, H., & Sharifi, N. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030452 · Cited by 406
Sex Steroid Actions in Male Bone
Vanderschueren, D., Laurent, M. R., Claessens, F., Gielen, E., Lagerquist, M. K., Vandenput, L., Börjesson, A. E., & Ohlsson, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1024 · Cited by 327
Self-citationSkeletal muscle tissue engineering: methods to form skeletal myotubes and their applications
Ostrovidov, S., Hosseini, V., Ahadian, S., Fujie, T., Parthiban, S. P., Ramalingam, M., Bae, H., Kaji, H., & Khademhosseini, A. (2014) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2013.0534 · Cited by 302
Molecular cell biology of androgen receptor signalling
Bennett, N. C., Gardiner, R. A., Hooper, J. D., Johnson, D. W., & Gobe, G. C. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.013 · Cited by 292
Dubois, V., Laurent, M., Boonen, S., Vanderschueren, D., & Claessens, F. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0883-3 · Cited by 197
Self-citationMinireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer
Lamont, K. R., & Tindall, D. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0469 · Cited by 150
Stepwise androgen receptor dimerization
van Royen, M. E., van Cappellen, W. A., de Vos, C., Houtsmuller, A. B., & Trapman, J. (2012) · Journal of Cell Science · doi:10.1242/jcs.096792 · Cited by 143
Androgen receptor coregulators: recruitment via the coactivator binding groove
van de Wijngaart, D. J., Dubbink, H. J., van Royen, M. E., Trapman, J., & Jenster, G. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.007 · Cited by 122
The hinge region in androgen receptor control
Clinckemalie, L., Vanderschueren, D., Boonen, S., & Claessens, F. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.019 · Cited by 104
Self-citationEvidence of androgen action in endometrial and ovarian cancers
Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0551 · Cited by 73
3,5-T2 Is an Alternative Ligand for the Thyroid Hormone Receptor β1
Mendoza, A., Navarrete-Ramírez, P., Hernández-Puga, G., Villalobos, P., Holzer, G., Renaud, J. P., Laudet, V., & Orozco, A. (2013) · Endocrinology · doi:10.1210/en.2013-1030 · Cited by 76
Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif
Jehle, K., Cato, L., Neeb, A., Muhle-Goll, C., Jung, N., Smith, E. W., Buzon, V., Carbó, L. R., Estébanez-Perpiñá, E., Schmitz, K., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534859 · Cited by 53
“It consists of an N-terminal domain for transactivation (subdivided into transactivation units 1 and 5; 1 (amino acids 100 –360) and 5 (amino acids 360 –528)), a highly conserved central DNA-binding domain (DBD), and a carboxyl-terminal ligand-binding domain (LBD) (4).”
BackgroundRegulation of androgen action during establishment of pregnancy
Gibson, D. A., Simitsidellis, I., & Saunders, P. T. K. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0027 · Cited by 42
Kim, N. R., David, K., Corbeels, K., Khalil, R., Antonio, L., Schollaert, D., Deboel, L., Ohlsson, C., Gustafsson, J.-Å., Vangoitsenhoven, R., et al. (2021) · Endocrinology · doi:10.1210/endocr/bqab045 · Cited by 21
Self-citation
Metadata
- Authors
- Claessens, F., Denayer, S., Van Tilborgh, N., Kerkhofs, S., Helsen, C., & Haelens, A.
- Venue
- Nuclear Receptor Signaling
- Publisher
- SAGE Publications
- Published
- 2008-01
- Volume
- 6
- Issue
- 1
- Pages
- e008-e008
- ISSN
- 1550-7629 (ISSN-L)
- OpenAlex
- W2069741812
- Cited by
- 231
- References
- 14
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
